Revenue: As of FY2025 Q2, the actual value is USD 292 K.EPS: As of FY2025 Q2, the actual value is USD 0.03.<h3>Segment Revenue</h3><ul><li>Subscription Revenue (Beam): $47 thousand for Q2 2025, a decrease of 67% from $141 thousand in Q2 2024. $105 thousand for H1 2025, a decrease of 69% from $342 thousand in H1 2024.</li><li>Web Imaging Revenue (Real-World Data): $108 thousand for Q2 2025, an increase of 26% from $86 thousand in Q2 2024. $187 thousand for H1 2025, an increase of 40% from $134 thousand in H1 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Margin: -$241 thousand for Q2 2025, a decrease from -$102 thousand in Q2 2024. -$445 thousand for H1 2025, a decrease from -$170 thousand in H1 2024.</li><li>General and Administrative Expenses: $1.2 million for Q2 2025, a decrease of 31% from $1.7 million in Q2 2024. $2.6 million for H1 2025, a decrease of 15% from $3.1 million in H1 2024.</li><li>Sales and Marketing Expenses: $257 thousand for Q2 2025, an increase of 2% from $253 thousand in Q2 2024. $542 thousand for H1 2025, an increase of 12% from $483 thousand in H1 2024.</li><li>Research and Development Expenses: $382 thousand for Q2 2025, consistent with $383 thousand in Q2 2024. $749 thousand for H1 2025, a decrease of 10% from $828 thousand in H1 2024.</li><li>Net Income (Loss): $2.98 million for Q2 2025, an increase from -$3.59 million in Q2 2024. $1.08 million for H1 2025, an increase from -$5.70 million in H1 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: -$4.2 million for H1 2025, compared to -$3.1 million for H1 2024.</li><li>Net Cash Provided by (Used in) Investing Activities: $1.3 million for H1 2025, compared to -$7 thousand for H1 2024.</li><li>Net Cash Provided by Financing Activities: $2.9 million for H1 2025, compared to $3.7 million for H1 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Change in Fair Value of PIPE Notes: -$1.09 million for Q2 2025, compared to $52 thousand in Q2 2024. -$1.22 million for H1 2025, compared to $33 thousand in H1 2024.</li><li>Change in Fair Value of Yorkville Note: -$34 thousand for Q2 2025, compared to $823 thousand in Q2 2024. -$64 thousand for H1 2025, compared to $823 thousand in H1 2024.</li><li>Change in Fair Value of Crypto Assets – Bitcoin: $174 thousand for Q2 2025, compared to $0 in Q2 2024. $837 thousand for H1 2025, compared to $0 in H1 2024.</li><li>Realized Gain on Sale of Crypto Assets – Bitcoin: -$314 thousand for Q2 2025, compared to $0 in Q2 2024. -$844 thousand for H1 2025, compared to $0 in H1 2024.</li><li>Gain on Troubled Debt Restructurings: -$3.71 million for Q2 2025, compared to $0 in Q2 2024. -$3.71 million for H1 2025, compared to $0 in H1 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue focusing on iRWD sales, leveraging its federated provider network and technology to meet rigorous Real World Data life science requirements. The decommissioning of the BEAM platform is part of this strategic shift.</li><li>Non-Core Business: The company has strategically invested in Bitcoin using excess cash from private placements and plans to liquidate Bitcoin holdings to support operations when needed.</li><li>Priority: The company aims to raise additional working capital through equity or debt offerings to fund its operations and capital requirements for at least 12 months from the date of the issuance of the condensed consolidated financial statements.</li></ul>

ONEMEDNET CORP C/WTS 07/11/2028 (TO PUR COM) | 10-Q: FY2025 Q2 Revenue: USD 292 K